| The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy IBDPCG Nguyen GC, Seow CH, Maxwell C Gastroenterology 150 (3), 734-757, 2016 | 497 | 2016 |
| Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised … L Peyrin-Biroulet, A Hart, P Bossuyt, M Long, M Allez, P Juillerat, ... The lancet Gastroenterology & hepatology 7 (2), 128-140, 2022 | 93 | 2022 |
| Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study S Danese, JF Colombel, M Lukas, JP Gisbert, G d'Haens, B Hayee, ... The lancet Gastroenterology & hepatology 7 (2), 118-127, 2022 | 80 | 2022 |
| SMAD3 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease SA Fowler, AN Ananthakrishnan, A Gardet, CR Stevens, JR Korzenik, ... Journal of Crohn's and Colitis 8 (8), 845-851, 2014 | 61 | 2014 |
| Effects of cancer treatment on inflammatory bowel disease remission and reactivation JE Axelrad, SA Fowler, S Friedman, AN Ananthakrishnan, V Yajnik Clinical Gastroenterology and Hepatology 10 (9), 1021-1027. e1, 2012 | 57 | 2012 |
| Non-pharmacological therapies for inflammatory bowel disease: Recommendations for self-care and physician guidance W Duff, N Haskey, G Potter, J Alcorn, P Hunter, S Fowler World Journal of Gastroenterology 24 (28), 3055, 2018 | 55 | 2018 |
| Development of a screening tool to detect nutrition risk in patients with inflammatory bowel disease N Haskey, JN Pena-Sanchez, JL Jones, SA Fowler Asia Pacific Journal of Clinical Nutrition 27 (4), 756-762, 2018 | 43 | 2018 |
| Impact of an integrated model of care on outcomes of patients with inflammatory bowel diseases: Evidence from a population-based study JN Peña-Sánchez, LM Lix, GF Teare, W Li, SA Fowler, JL Jones Journal of Crohn's and Colitis 11 (12), 1471-1479, 2017 | 33 | 2017 |
| Elevation of serum pyruvate kinase M2 (PKM2) in IBD and its relationship to IBD indices AA Almousa, M Morris, S Fowler, J Jones, J Alcorn Clinical biochemistry 53, 19-24, 2018 | 32 | 2018 |
| Efficacy and safety of natalizumab in Crohn’s disease patients treated at 6 Boston academic hospitals P Juillerat, SK Wasan, SA Fowler, S Friedman, VK Pabby, JA Coukas, ... Inflammatory bowel diseases 19 (11), 2457-2463, 2013 | 32 | 2013 |
| Influence of flaxseed lignan supplementation to older adults on biochemical and functional outcome measures of inflammation Y Di, J Jones, K Mansell, S Whiting, S Fowler, L Thorpe, J Billinsky, ... Journal of the American College of Nutrition 36 (8), 646-653, 2017 | 31 | 2017 |
| Endoscopist‐Administered Propofol: A Retrospective Safety Study JWI Morse, SA Fowler, AL Morse Canadian Journal of Gastroenterology and Hepatology 22 (7), 617-620, 2008 | 31 | 2008 |
| Increasing prevalence and stable incidence rates of inflammatory bowel disease among first nations: population-based evidence from a western Canadian province JN Peña-Sánchez, JA Osei, JD Marques Santos, D Jennings, M Andkhoie, ... Inflammatory bowel diseases 28 (4), 514-522, 2022 | 29 | 2022 |
| Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease N GC, B K, A W, B B, J JL, W AV, F S, H S, H VW, K GG, K R, M SK, R J, ... Inflammatory Bowel Disease 23 (6), 858-865, 2017 | 29 | 2017 |
| Metagenomic Characterization of Microbial Communities In Situ Within the Deeper Layers of the Ileum in Crohn’s Disease YV Pedamallu CD, Bhatt AS, Bullman S, Fowler S, Freeman SS, Durand J, Jung J ... Cellular and Molecular Gastroenterology and Hepatology 2 (5), 563-566, 2016 | 28 | 2016 |
| Integrated model of care for polycystic ovary syndrome CT Tay, LJ Moran, CN Wijeyaratne, LM Redman, RJ Norman, HJ Teede, ... Seminars in reproductive medicine 36 (01), 086-094, 2018 | 23 | 2018 |
| Biomarker-based models outperform patient-reported scores in predicting endoscopic inflammatory disease activity MW Morris, SA Stewart, C Heisler, WJ Sandborn, EV Loftus, GA Zello, ... Inflammatory bowel diseases 24 (2), 277-285, 2018 | 22 | 2018 |
| Guselkumab in patients with moderately to severely active ulcerative colitis: QUASAR phase 2b induction study L Peyrin-Biroulet, JR Allegretti, DT Rubin, B Bressler, M Germinaro, ... Gastroenterology 165 (6), 1443-1457, 2023 | 20 | 2023 |
| Canadian Consensus Statements on the transition of adolescents and young adults with inflammatory bowel disease from pediatric to adult care: a collaborative initiative between … N Fu, N Bollegala, K Jacobson, KI Kroeker, K Frost, W Afif, W El-Matary, ... Journal of the Canadian Association of Gastroenterology 5 (3), 105-115, 2022 | 16 | 2022 |
| Protocol for a 24-week randomized controlled study of once-daily oral dose of flax lignan to healthy older adults J Alcorn, S Whiting, N Viveky, Y Di, K Mansell, S Fowler, L Thorpe, ... JMIR research protocols 6 (2), e6817, 2017 | 15 | 2017 |
